Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) had Stock-Based Compensation of $0.07M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.98M |
|
$0.03M |
|
$8.09M |
|
$17.07M |
|
$3.73M |
|
-- |
|
$0.44M |
|
$4.17M |
|
$12.90M |
|
$4.83M |
|
$12.90M |
|
3.73M |
|
| Cash Flow Statement Financials | |
$-6.19M |
|
$-0.85M |
|
$-0.09M |
|
$11.45M |
|
$4.33M |
|
$-7.12M |
|
|
Stock-Based Compensation |
$0.07M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|